82
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Studies on HBcAg-rBlo t 5-21 Fusion Protein Vaccine That Alleviates Blomia tropicalis Airway Inflammation

ORCID Icon, , , , &
Pages 6343-6355 | Received 16 Jul 2022, Accepted 06 Nov 2022, Published online: 18 Nov 2022

References

  • Pawankar R. Allergic diseases and asthma: a global public health concern and a call to action. World Allergy Organ J. 2014;7:12. doi:10.1186/1939-4551-7-12
  • Frankland AW. Asthma and mites. Postgrad Med J. 1971;47:178–180. doi:10.1136/pgmj.47.545.178
  • Platts-Mills TA, De Weck AL, Aalberse RC, et al. Dust mite allergens and asthma--a worldwide problem. J Allergy Clin Immunol. 1989;83:416–427. doi:10.1016/0091-6749(89)90128-0
  • Guilleminault L, Viala-Gastan C. Blomia tropicalis: un acarien sous les tropiques [Blomia tropicalis: a house dust mite in the tropics]. Rev Mal Respir. 2017;34:791–801. French. doi:10.1016/j.rmr.2016.10.877
  • Susanto AJ, Rengganis I, Rumende CM, Harimurti K. The differences in serum quantitative specific ige levels induced by dermatophagoides pteronyssinus, dermatophagoides farinae and Blomia tropicalis sensitization in intermittent and persistent allergic asthma. Acta Med Indones. 2017;49:299–306.
  • Colloff MJ. Effects of temperature and relative humidity on development times and mortality of eggs from laboratory and wild populations of the European house-dust mite Dermatophagoides pteronyssinus (Acari: pyroglyphidae). Exp Appl Acarol. 1987;3:279–289. doi:10.1007/BF01193165
  • Trombone AP, Tobias KR, Ferriani VP, et al. Use of a chimeric ELISA to investigate immunoglobulin E antibody responses to Der p 1 and Der p 2 in mite-allergic patients with asthma, wheezing and/or rhinitis. Clin Exp Allergy. 2002;32:1323–1328. doi:10.1046/j.1365-2745.2002.01455.x
  • Pytelková J, Lepšík M, Sanda M, Talacko P, Marešová L, Mareš M. Enzymatic activity and immunoreactivity of Aca s 4, an alpha-amylase allergen from the storage mite Acarus siro. BMC Biochem. 2012;13:3. doi:10.1186/1471-2091-13-3
  • Jacquet A. Innate immune responses in house dust mite allergy. ISRN Allergy. 2013;2013:735031. doi:10.1155/2013/735031
  • Carnés J, Iraola V, Cho SH, Esch RE. Mite allergen extracts and clinical practice. Ann Allergy Asthma Immunol. 2017;118:249–256. doi:10.1016/j.anai.2016.08.018
  • Ferreira F, Wolf M, Wallner M. Molecular approach to allergy diagnosis and therapy. Yonsei Med J. 2014;55:839–852. doi:10.3349/ymj.2014.55.4.839
  • Valenta R, Campana R, Focke-Tejkl M, Niederberger V. Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: lessons from the past and novel mechanisms of action for the future. J Allergy Clin Immunol. 2016;137:351–357. doi:10.1016/j.jaci.2015.12.1299
  • Wallner M, Hauser M, Himly M, et al. Reshaping the Bet v 1 fold modulates T(H) polarization. J Allergy Clin Immunol. 2011;127:1571–1578.e1579. doi:10.1016/j.jaci.2011.01.064
  • Banerjee S, Weber M, Blatt K, et al. Conversion of Der p 23, a new major house dust mite allergen, into a hypoallergenic vaccine. J Immunol. 2014;192:4867–4875. doi:10.4049/jimmunol.1400064
  • Curin M, Weber M, Thalhamer T, et al. Hypoallergenic derivatives of Fel d 1 obtained by rational reassembly for allergy vaccination and tolerance induction. Clin Exp Allergy. 2014;44:882–894. doi:10.1111/cea.12294
  • Comberiati P, Colavita L, Minniti F, et al. Utility of specific IgE to Ara h 2 in Italian allergic and tolerant children sensitized to peanut. Int J Mol Cell Med. 2016;5:160–166.
  • Kinaciyan T, Nagl B, Faustmann S, Kopp S, Wolkersdorfer M, Bohle B. Recombinant Mal d 1 facilitates sublingual challenge tests of birch pollen-allergic patients with apple allergy. Allergy. 2016;71:272–274. doi:10.1111/all.12781
  • Carvalho Kdos A, de Melo-Neto OP, Magalhães FB, et al. Blomia tropicalis Blo t 5 and Blo t 21 recombinant allergens might confer higher specificity to serodiagnostic assays than whole mite extract. BMC Immunol. 2013;14:11. doi:10.1186/1471-2172-14-11
  • Chan SL, Ong TC, Gao YF, et al. Nuclear magnetic resonance structure and IgE epitopes of Blo t 5, a major dust mite allergen. J Immunol. 2008;181:2586–2596. doi:10.4049/jimmunol.181.4.2586
  • Naik MT, Chang CF, Kuo IC, et al. Roles of structure and structural dynamics in the antibody recognition of the allergen proteins: an NMR study on Blomia tropicalis major allergen. Structure. 2008;16:125–136. doi:10.1016/j.str.2007.10.022
  • Tan KW, Ong TC, Gao YF, et al. NMR structure and IgE epitopes of Blo t 21, a major dust mite allergen from Blomia tropicalis. J Biol Chem. 2012;287:34776–34785. doi:10.1074/jbc.M112.348730
  • Lahiani S, Dumez ME, Khemili S, Bitam I, Gilis D, Galleni M. Cross-reactivity between major IgE epitopes of family 5 allergens from dermatophagoides pteronyssinus and Blomia tropicalis. Int Arch Allergy Immunol. 2019;178:10–18. doi:10.1159/000492871
  • Cates EC, Fattouh R, Wattie J, et al. Intranasal exposure of mice to house dust mite elicits allergic airway inflammation via a GM-CSF-mediated mechanism. J Immunol. 2004;173:6384–6392. doi:10.4049/jimmunol.173.10.6384
  • Johnson JR, Wiley RE, Fattouh R, et al. Continuous exposure to house dust mite elicits chronic airway inflammation and structural remodeling. Am J Respir Crit Care Med. 2004;169:378–385. doi:10.1164/rccm.200308-1094OC
  • Fattouh R, Pouladi MA, Alvarez D, et al. House dust mite facilitates ovalbumin-specific allergic sensitization and airway inflammation. Am J Respir Crit Care Med. 2005;172:314–321. doi:10.1164/rccm.200502-198OC
  • Baqueiro T, Russo M, Silva VM, et al. Respiratory allergy to Blomia tropicalis: immune response in four syngeneic mouse strains and assessment of a low allergen-dose, short-term experimental model. Respir Res. 2010;11:51. doi:10.1186/1465-9921-11-51
  • Barboza R, Câmara NO, Gomes E, et al. Endotoxin exposure during sensitization to Blomia tropicalis allergens shifts TH2 immunity towards a TH17-mediated airway neutrophilic inflammation: role of TLR4 and TLR2. PLoS One. 2013;8:e67115. doi:10.1371/journal.pone.0067115
  • Zhou Q, Ho AW, Schlitzer A, et al. GM-CSF-licensed CD11b+ lung dendritic cells orchestrate Th2 immunity to Blomia tropicalis. J Immunol. 2014;193:496–509. doi:10.4049/jimmunol.1303138
  • Chua YL, Liong KH, Huang C-H. Blomia tropicalis –specific TCR transgenic Th2 cells induce inducible BALT and severe asthma in mice by an IL-4/IL-13–dependent mechanism. J Immunol. 2016;197:3771–3781. doi:10.4049/jimmunol.1502676
  • Focke M, Swoboda I, Marth K, Valenta R. Developments in allergen-specific immunotherapy: from allergen extracts to allergy vaccines bypassing allergen-specific immunoglobulin E and T cell reactivity. Clin Exp Allergy. 2010;40:385–397. doi:10.1111/j.1365-2222.2009.03443.x
  • Wynne SA, Crowther RA, Leslie AG. The crystal structure of the human hepatitis B virus capsid. Mol Cell. 1999;3:771–780. doi:10.1016/S1097-2765(01)80009-5
  • Schödel F, Peterson D, Hughes J, Wirtz R, Milich D. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: i. presentation of foreign epitopes. J Biotechnol. 1996;44:91–96. doi:10.1016/0168-1656(95)00118-2
  • Edman JCHRA, Valenzuela P, Valenzuela P, et al. Synthesis of hepatitis B surface and core antigens in E. coli. Nature. 1981;291:503–506. doi:10.1038/291503a0
  • Miyanohara AIT, Araki M, Araki M, et al. Expression of hepatitis B virus core antigen gene in saccharomyces cerevisiae. J Virol. 1986;59:176–180. doi:10.1128/jvi.59.1.176-180.1986
  • Jean-Jean OLM, Will H, Hans W, et al. Expression mechanism of the hepatitis B virus (HBV) C gene and biosynthesis of HBe antigen. Virology. 1989;170:99–106. doi:10.1016/0042-6822(89)90356-5
  • Hirschman SZPP, Garfinkel E, Garfinkel E, et al. Expression of cloned hepatitis B virus DNA in human cell cultures. Proc Natl Acad Sci USA. 1980;77:5507–5511. doi:10.1073/pnas.77.9.5507
  • Huang Z, Santi L, LePore K, Kilbourne J, Arntzen CJ, Mason HS. Rapid, high-level production of hepatitis B core antigen in plant leaf and its immunogenicity in mice. Vaccine. 2006;24:2506–2513. doi:10.1016/j.vaccine.2005.12.024
  • Conway JF, Watts NR, Belnap DM, et al. Characterization of a conformational epitope on hepatitis B virus core antigen and quasi equivalent variations in antibody binding. J Virol. 2003;77:6466–6473. doi:10.1128/JVI.77.11.6466-6473.2003
  • Salfeld J, Pfaff E, Noah M, Schaller H. Antigenic determinants and functional domains in core antigen and e antigen from hepatitis B virus. J Virol. 1989;63:798–808. doi:10.1128/jvi.63.2.798-808.1989
  • Kratz PA, Böttcher B, Nassal M. Native display of complete foreign protein domains on the surface of hepatitis B virus capsids. Proc Natl Acad Sci USA. 1999;96:1915–1920. doi:10.1073/pnas.96.5.1915
  • Skamel C, Ploss M, Böttcher B, et al. Hepatitis B virus capsid-like particles can display the complete, dimeric outer surface protein C and stimulate production of protective antibody responses against Borrelia burgdorferi infection. J Biol Chem. 2006;281:17474–17481. doi:10.1074/jbc.M513571200
  • Georas SN, Guo J, De Fanis U, Casolaro V. T-helper cell type-2 regulation in allergic disease. Eur Respir J. 2005;26:1119–1137. doi:10.1183/09031936.05.00006005
  • Chung RGSAKF, Chung KF. Future treatments of allergic diseases and asthma. Br Med Bull. 2000;56:1037–1053. doi:10.1258/0007142001903526
  • Lefranc GCH, Van Loghem E, Van Loghem E, et al. Simultaneous absence of the human IgG1, IgG2, IgG4 and IgAl subclasses: immunological and immunogenetical considerations. Eur J Immunol. 1983;13:240–244. doi:10.1002/eji.1830130312
  • James LK, Shamji MH, Walker SM, et al. Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies. J Allergy Clin Immunol. 2011;127:509–516.e501–505. doi:10.1016/j.jaci.2010.12.1080
  • Zhao D, Lai X, Tian M, et al. The functional IgE-blocking factor induced by allergen-specific immunotherapy correlates with IgG4 antibodies and a decrease of symptoms in house dust mite-allergic children. Int Arch Allergy Immunol. 2016;169:113–120. doi:10.1159/000444391
  • Tourdot S, Airouche S, Berjont N, et al. Efficacy of sublingual vectorized recombinant Bet v 1a in a mouse model of birch pollen allergic asthma. Vaccine. 2013;31:2628–2637. doi:10.1016/j.vaccine.2013.03.041